| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in HTFL over the last quarter tilts toward selling: insiders offloaded a net 304,105 shares worth roughly $14.2M. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
On the other side, 1 insider reduced a position over the period. HTFL sits in the Health Care Technology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.50M | $248.16M | - | |
| CEO | 283.0K | $14.03M | -38,900 | |
| Dir | 226.8K | $1.89M | - | |
| Dir | 188.2K | $3.58M | - | |
| CFO | 155.2K | $7.88M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Rogers Campbell | Chief Medical Officer | Sale+OE | 64,533 | $24.64 | $1,590,093.12 | -44.3% | +19.8% | - | |
| Mar 19, 2026 | Rogers Campbell | Chief Medical Officer | Sale+OE | 64,533 | $25.69 | $1,658,033.46 | -45.1% | +26.8% | - | |
| Mar 18, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 9,725 | $25.00 | $243,125.00 | -1.7% | +25.8% | - | |
| Mar 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 12,837 | $22.66 | $290,886.42 | -2.2% | +25.9% | - | |
| Mar 5, 2026 | Cullivan Julie A | Director | Sell | 9,122 | $25.00 | $228,050.00 | -25.1% | +16.0% | - | |
| Feb 12, 2026 | Rogers Campbell | Chief Medical Officer | Sale+OE | 65,153 | $24.49 | $1,595,486.21 | -46.1% | +38.7% | - | |
| Feb 10, 2026 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $27.46 | $619,552.52 | -3.7% | +7.7% | - | |
| Feb 5, 2026 | Cullivan Julie A | Director | Sell | 8,000 | $27.32 | $218,560.00 | -18.0% | +16.5% | - | |
| Feb 4, 2026 | Bain Capital Life Sciences Investors, LLC48 | 10% Owner | Sell | 2,000,000 | $28.05 | $56,100,000.00 | -16.1% | +6.5% | - | |
| Dec 16, 2025 | Lightcap Jeffrey C | Director | Buy | 40,000 | $26.34 | $1,053,680.00 | New | -20.7% | - |